Probiota Asia 2019

Watch – AB Biotics on why probiotics for cognitive health have huge potential in APAC

By Gary Scattergood contact

- Last updated on GMT

Related tags: Probiota, Nutrition, P&g beauty business

AB Biotics has pledged to continue investing in clinical research to back-up the cognitive benefits of L. plantarum DR7 after acquiring the exclusive global licensing of the strain.

We spoke with the firm’s founder Miquel Bonachera at our recent Probiota Asia Summit in Singapore.

In this video, he explains the reasons for investing in the strain, which was discovered during a collaboration between Clinical Nutrition Sdn Bhd and University Sains Malaysia in 2014.

In addition to discussing the future research priorities and the latest understanding around the strain's mechanism of action, he also evaluates the business opportunities for new product development in the cognitive health space across a raft of life stages.

Watch the video for more.

Related news

Related products

show more

HRB probiotics: The gift of life for infant health

HRB probiotics: The gift of life for infant health

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Technical / White Paper

Bifidobacteria are among the first colonizers of human gut, and certain species are recognised as Human-Residential Bifidobacteria (HRB) - the natural...

Aquamin & Microbiome Enhance Immunity Naturally

Aquamin & Microbiome Enhance Immunity Naturally

Marigot Ltd | 24-Jun-2020 | Technical / White Paper

Aquamin is a unique, natural plant multi-mineral offering for gut health with 39 peer reviewed publications to support its unique health properties, enhancing...

Related suppliers

Follow us

Products

View more

Webinars